Biotech U

Gain deep knowledge on the biotechnology industry

As biotechnology changes paradigms in medicine, agriculture, and industrial processes, there is a pressing need for cross-trained individuals capable of developing new innovations and bringing them to market. Biotech U helps you understand the business of biotechnology, how to start and manage biotechnology companies, and how to better service the needs of biotechnology companies.

Biotech U goes beyond simple 'science for non-scientists' or 'mini MBA' offerings, and describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define its scope.

Biotech U is based on the leading business-of-biotechnology text, Building Biotechnology, which has been adopted by more than 50 schools, and is taught by Yali Friedman, Ph.D., chief editor of the Journal of Commercial Biotechnology and a former instructor in biotechnology management at the National Institutes of Health.

Optimized for your computer, tablet, or phone

About the Course

Course Requirements

  • This course presumes no former training in business, science, or law

Intended Audience

  • New hires to biotechnology and related companies
  • New biotechnology company founders
  • Entrepreneurial scientists
  • Entrepreneurs and established businesses seeking to enter the biotechnology industry

Course Objectives

  • Understand the commercial factors driving and constraining biotechnology development
  • Learn how biotechnology is regulated, and how regulations can both limit and drive innovation
  • Learn about patents and other forms of intellectual property protection in biotechnology, and why they are crucial for innovation
  • Learn about domestic and international biotechnology policy decisions and how to balance innovation incentives with economic realities
  • Learn about the science behind biotechnology, and its applications

Course Content

More than 6 hours of contents in 50+ videos



The Development of Biotechnology

The Development of Biotechnology
Knowledge and Skills
Industry Trends
Company Examples: Genentech and Amgen

The Science of Biotechnology

The Science of Biotechnology

Introduction to Molecular Biology

Information Flow in Molecular Biology
DNA, Genes, and Protein
The Big Picture

Drug Development

Biotechnology vs. Pharmaceutical Drug Development
The Five Basic Steps of Drug Development
Qualities of a Good Drug

Tools and Techniques

Tools and Techniques Overview
Genomics and Proteomics
Biologic Delivery and Nanotechnology


Applications Overview
Green Biotechnology: Agriculture
White Biotechnology: Industrial Processes and Bio-based Products
Red Biotechnology: Medical Applications

Patents, Regulation, and Policy

Patents, Regulation, and Policy

Intellectual Property

Intellectual Property Overview
Patent Challenge and Exemptions
Trade Secrets
The Role of Intellectual Property in Biotechnology


Regulation Overview
Food and Drug Administration Clinical Trials
FDA Incentives and Other Regulations
Department of Agriculture and Environmental Protection Agency


Policy Overview
Promoting Biotechnology
Balancing Innovation Incentives with Economic Contraints

The Business of Biotechnology

The Business of Biotechnology

Biotechnology Company Fundamentals

Biotechnology Company Fundamentals Overview
Company Formation
Business Model
Company Characteristics


Finance Overview
Development Stages and Funding
Public Markets
Other Funding Sources


Marketing Overview
Marketing as a Guide for R&D
Market Structure and Marketing Environment

Managing Biotechnology

Managing Biotechnology Overview
Starting Up
Managing R&D
Dealing with Failure

Final Words

Final Words

About the Author

Yali Friedman Yali Friedman, Ph.D., is founder of thinkBiotech and chief editor and publisher of the Journal of Commercial Biotechnology. His first book, Building Biotechnology, is used as a course text in dozens of biotechnology programs. His other books include Best Practices in Biotechnology Education and Best Practices in Biotechnology Business Development. He is also a member of the board of directors of AmericasHealth, serves on the science advisory board of Chakra Biotech, is an associate of the World Technology Network, and also serves as a judge for the Biotech Humanitarian Award and the Maryland Incubator Company of the Year Award.

Dr. Friedman has strong exposure to leading issues in international biotechnology. He created and continues to edit a global biotechnology innovation scorecard for Scientific American Worldview, a global biotechnology perspective profiling biotechnology industries and innovation capacity in dozens of countries, and has been invited to participate in biotechnology industry development forums for international groups such as APEC and the Asian Productivity Organization, and for individual countries such as Japan, Canada, Germany, the Philippines, and Turkey.

Dr. Friedman taught biotechnology management at the National Institutes of Health and continues to regularly guest-lecture for other biotechnology education programs. He writes and speaks on diverse topics such as biotechnology entrepreneurship, strategies to cope with a lack of management talent and capital when developing companies outside of established hubs, and new paradigms in technology-based economic development.

Dr. Friedman has a long history in biotechnology media. He created the first blog on the business of biotechnology for a NY Times company, which was named to Forbes 'Best of the Web' list. His other projects include the Student Guide to DNA Based Computers, sponsored by FUJI Television,, and, a pharmaceutical industry competitive intelligence service based on a business plan that was awarded second place in the Panasci Entrepreneurial Awards Competition.

Contact Dr. Friedman

Onsite Bootcamps

Customized onsite bootcamps are also available to train your staff.

For more information, Contact Dr. Friedman

Get the Textbook

Online Biotechnology Business Primer Course This course is based on Building Biotechnology, the leading text on the business of biotechnology. Building Biotechnolgy has been adopted by more than 50 schools, including Georgetown University, Johns Hopkins, the Karolinska Institute, Berkeley, UCSF, and the National Institutes of Health.

Building Biotechnology helps readers understand the business of biotechnology, how to start and manage biotechnology companies, and how to better service the needs of biotechnology companies. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define its scope.

The videos in this course are based on the author's teaching experiences, and follow the chapters in the book. In developing this online course it was desired to do more than simply read through the chapters—the online course adds substantial color to the content of the book.

While the text is not necessary for the course, it can be useful to follow along with the videos, or as a handy reference once you are done with the video lectures.

Buy Building Biotechnology at

Journal of Commercial Biotechnology

Journal of Commercial Biotechnology For more advanced coverage of biotechnology, see the Journal of Commercial Biotechnology.

The Journal of Commercial Biotechnology, in print since 1994, is the definitive international quarterly publication for bioscience business professionals. The Journal is designed specifically for those professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up-to-date with current issues and industry trends.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

Journal of Commercial Biotechnology Sample Papers

Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.